Evidence map›Paper›PMID 29930985›Full record

ArticleCellular and molecular gastroenterology and hepatology2018

Interleukin-17A Promotes Parietal Cell Atrophy by Inducing Apoptosis.

Kevin A Bockerstett, Luciana H Osaki, Christine P Petersen, Catherine W Cai, Chun Fung Wong, Thanh-Long M Nguyen, Eric L Ford, Daniel F Hoft, Jason C Mills, James R Goldenring and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cellular and molecular gastroenterology and hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Autoimmune gastritis: emerging insights and clinical management.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  3. Review
  4. Recent advances in spasmolytic polypeptide expressing metaplasia research.World journal of gastrointestinal oncology · 2026
    Review
  5. Immunological mechanisms of autoimmune gastritis.Clinical and experimental medicine · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Kevin A BockerstettDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St Louis, Missouri.
Luciana H OsakiDivision of Gastroenterology, Departments of Medicine, Pathology and Immunology, Developmental Biology, Washington University School of Medicine, St Louis, Missouri.
Christine P PetersenNashville VA Medical Center and Departments of Surgery and Cell and Developmental Biology, Epithelial Biology Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Catherine W CaiDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St Louis, Missouri.
Chun Fung WongDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St Louis, Missouri.
Thanh-Long M NguyenDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St Louis, Missouri.
Eric L FordDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St Louis, Missouri.
Daniel F HoftDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St Louis, Missouri.
Jason C MillsDivision of Gastroenterology, Departments of Medicine, Pathology and Immunology, Developmental Biology, Washington University School of Medicine, St Louis, Missouri.
James R GoldenringNashville VA Medical Center and Departments of Surgery and Cell and Developmental Biology, Epithelial Biology Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Richard J DiPaoloDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St Louis, Missouri.
Saint Louis University · USVanderbilt University · USWashington University in St. Louis · US

Funding

Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
REGULATION OF ATROPHY-INDUCED PROGENITOR CELLS IN THE GASTRIC CORPUSR01DK094989 · NIDDK · WASHINGTON UNIVERSITY · PI Jason C Mills · 2012 to 2026
$6.1M
Induction and Evolution of Metaplasia in the StomachR01DK101332 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Eunyoung Choi, James Richard Goldenring · 2014 to 2026
$5.9M
MECHANISMS OF CHIEF CELL DEDIFFERENTIATIONR01DK105129 · NIDDK · WASHINGTON UNIVERSITY · PI Jason C Mills · 2015 to 2026
$5.4M
The Role of EBI3 in Regulating Gastritis and Gastric CarcinogenesisR01DK110406 · NIDDK · SAINT LOUIS UNIVERSITY · PI DIPAOLO, RICHARD J · 2016 to 2020
$2.3M
Inflammatory mediators promote the development of metaplasia in the stomachF31DK104600 · NIDDK · VANDERBILT UNIVERSITY · PI PETERSEN, CHRISTINE POPE · 2014 to 2015
$55k
Oxyntic Atrophy and Novel Gastric Lineages.I01BX000930 · VA · VETERANS HEALTH ADMINISTRATION · PI GOLDENRING, JAMES RICHARD · 2011 to 2025
–
BLRD VA I01 BX000930NIDDK NIH HHS F31 DK104600NIDDK NIH HHS P30 DK052574NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK094989NIDDK NIH HHS R01 DK101332NIDDK NIH HHS R01 DK105129NIDDK NIH HHS R01 DK110406
6 · The paper itself

Abstract

BACKGROUND &

aimsAtrophic gastritis caused by chronic inflammation in the gastric mucosa leads to the loss of gastric glandular cells, including acid-secreting parietal cells. Parietal cell atrophy in a setting of chronic inflammation induces spasmolytic polypeptide expressing metaplasia, a critical step in gastric carcinogenesis. However, the mechanisms by which inflammation causes parietal cell atrophy and spasmolytic polypeptide expressing metaplasia are not well defined. We investigated the role of interleukin-17A (IL-17A) in causing parietal cell atrophy.

methodsA mouse model of autoimmune atrophic gastritis was used to examine IL-17A production during early and late stages of disease. Organoids derived from corpus glands were used to determine the direct effects of IL-17A on gastric epithelial cells. Immunofluorescent staining was used to examine IL-17A receptors and the direct effect of signaling on parietal cells. Mice were infected with an IL-17A-producing adenovirus to determine the effects of IL-17A on parietal cells in vivo. Finally, IL-17A neutralizing antibodies were administered to mice with active atrophic gastritis to evaluate the effects on parietal cell atrophy and metaplasia.

resultsIncreased IL-17A correlated with disease severity in mice with chronic atrophic gastritis. IL-17A caused caspase-dependent gastric organoid degeneration, which could not be rescued with a necroptosis inhibitor. Parietal cells expressed IL-17A receptors and IL-17A treatment induced apoptosis in parietal cells. Overexpressing IL-17A in vivo induced caspase-3 activation and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling staining in parietal cells. Finally, IL-17A neutralizing antibody decreased parietal cell atrophy and metaplasia in mice with chronic atrophic gastritis.

conclusionsThese data identify IL-17A as a cytokine that promotes parietal cell apoptosis during atrophic gastritis, a precursor lesion for gastric cancer.

Indexed as

ADV, adenovirusApoptosisAtrophyIL-17AIL-17A, interleukin 17AMetaplasiarIL-17A, recombinant interleukin 17ASPEM, spasmolytic polypeptide-expressing metaplasiaTh, T helperTUNEL, terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate nick-end labeling

Identifiers

PMID29930985
PMCPMC6009015
OpenAlexW2782400666

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.